HU180042B - Process for producing 2,2-dimethyl-pename-3-carboxylic acid-1,1-dioxide derivatives - Google Patents

Process for producing 2,2-dimethyl-pename-3-carboxylic acid-1,1-dioxide derivatives Download PDF

Info

Publication number
HU180042B
HU180042B HU78PI630A HUPI000630A HU180042B HU 180042 B HU180042 B HU 180042B HU 78PI630 A HU78PI630 A HU 78PI630A HU PI000630 A HUPI000630 A HU PI000630A HU 180042 B HU180042 B HU 180042B
Authority
HU
Hungary
Prior art keywords
formula
carboxylic acid
compound
dimethyl
penam
Prior art date
Application number
HU78PI630A
Other languages
German (de)
English (en)
Hungarian (hu)
Inventor
Wayne E Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU180042(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of HU180042B publication Critical patent/HU180042B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU78PI630A 1977-06-07 1978-06-06 Process for producing 2,2-dimethyl-pename-3-carboxylic acid-1,1-dioxide derivatives HU180042B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (1)

Publication Number Publication Date
HU180042B true HU180042B (en) 1983-01-28

Family

ID=27122691

Family Applications (1)

Application Number Title Priority Date Filing Date
HU78PI630A HU180042B (en) 1977-06-07 1978-06-06 Process for producing 2,2-dimethyl-pename-3-carboxylic acid-1,1-dioxide derivatives

Country Status (35)

Country Link
AR (1) AR224111A1 (fr)
AT (2) AT360649B (fr)
AU (1) AU513636B2 (fr)
BE (1) BE867859A (fr)
BG (2) BG34615A3 (fr)
CH (1) CH634073A5 (fr)
CS (1) CS208472B2 (fr)
DD (2) DD148585A5 (fr)
DE (2) DE2824535C3 (fr)
DK (1) DK155740C (fr)
EG (1) EG13869A (fr)
FI (1) FI66003C (fr)
FR (2) FR2393804A1 (fr)
GB (1) GB2000138B (fr)
GR (1) GR72255B (fr)
HK (1) HK13184A (fr)
HU (1) HU180042B (fr)
IE (1) IE47079B1 (fr)
IL (2) IL54867A (fr)
IN (1) IN149747B (fr)
IT (1) IT1096381B (fr)
KE (1) KE3355A (fr)
LU (1) LU79774A1 (fr)
MY (1) MY8500092A (fr)
NL (2) NL180009C (fr)
NO (2) NO151746C (fr)
NZ (1) NZ187476A (fr)
OA (1) OA05964A (fr)
PH (3) PH26810A (fr)
PL (1) PL114501B1 (fr)
PT (1) PT68146A (fr)
SE (2) SE436206B (fr)
SG (1) SG65383G (fr)
SU (1) SU860706A1 (fr)
YU (1) YU41829B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (fr) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (fr) * 1978-12-11 1983-12-13 Eric M. Gordon Acide 6-bromopenicillanique sulfone
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4309347A (en) 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3051044C2 (fr) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
DE3261759D1 (en) * 1981-07-15 1985-02-14 Kanebo Ltd Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76526B (en) * 1982-04-19 1986-01-21 Gist Brocades Nv Preparation of 6-alpha-bromo- and/or 6,6-dibromopenicillanic acid 1,1-dioxides
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (fr) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Procédé de préparation de 1,1-dioxyde d'acide 6,6-dibromopénicillanique
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
DE3780112T2 (de) * 1986-04-10 1992-12-24 Leo Pharm Prod Ltd Verfahren zur herstellung von penicillansaeure-derivaten.
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (fr) * 1977-05-09 1979-01-18
JPS5439090A (en) * 1977-07-13 1979-03-24 Glaxo Group Ltd Betaalactam compound and its preparation

Also Published As

Publication number Publication date
GB2000138B (en) 1982-03-03
DE2824535B2 (de) 1980-05-14
AU513636B2 (en) 1980-12-11
SE447995B (sv) 1987-01-12
LU79774A1 (fr) 1980-01-22
KE3355A (en) 1983-12-16
NO151746B (no) 1985-02-18
NL930064I1 (nl) 1993-09-01
FR2393804A1 (fr) 1979-01-05
SE8305916D0 (sv) 1983-10-27
ATA411278A (de) 1980-06-15
DD140888A5 (de) 1980-04-02
DE2824535C3 (de) 1981-01-22
AR224111A1 (es) 1981-10-30
HK13184A (en) 1984-02-24
PL114501B1 (en) 1981-02-28
DE2857263B2 (de) 1981-04-23
NO152448B (no) 1985-06-24
IN149747B (fr) 1982-04-03
NO151746C (no) 1985-06-05
BG34615A3 (en) 1983-10-15
FI66003B (fi) 1984-04-30
BG34614A3 (en) 1983-10-15
CH634073A5 (en) 1983-01-14
NL7806126A (nl) 1978-12-11
IT7824270A0 (it) 1978-06-06
NZ187476A (en) 1982-08-17
NO152448C (no) 1985-10-02
GR72255B (fr) 1983-10-06
MY8500092A (en) 1985-12-31
FI781800A (fi) 1978-12-08
DK155740C (da) 1989-10-23
SE436206B (sv) 1984-11-19
CS208472B2 (en) 1981-09-15
OA05964A (fr) 1981-06-30
IE781140L (en) 1978-12-07
DK251478A (da) 1978-12-08
FR2393805A1 (fr) 1979-01-05
IL62168A0 (en) 1981-03-31
FR2393805B1 (fr) 1984-02-24
FI66003C (fi) 1984-08-10
IL54867A0 (en) 1978-08-31
SE7806628L (sv) 1978-12-08
AT360649B (de) 1981-01-26
PH16465A (en) 1983-10-20
PH21116A (en) 1987-07-16
IE47079B1 (en) 1983-12-14
YU117078A (en) 1983-01-21
DK155740B (da) 1989-05-08
SU860706A1 (ru) 1981-08-30
PH26810A (en) 1992-11-05
GB2000138A (en) 1979-01-04
BE867859A (fr) 1978-12-06
AU3683878A (en) 1979-12-06
DD148585A5 (de) 1981-06-03
NL930064I2 (nl) 1994-04-18
NO823126L (no) 1978-12-08
DE2857263C3 (de) 1981-12-17
SE8305916L (sv) 1983-10-27
EG13869A (en) 1983-03-31
YU41829B (en) 1988-02-29
FR2393804B1 (fr) 1980-11-07
PL207396A1 (pl) 1979-06-04
ATA128580A (de) 1981-02-15
NL180009C (nl) 1986-12-16
PT68146A (en) 1978-07-01
NO781970L (no) 1978-12-08
IL54867A (en) 1981-11-30
IT1096381B (it) 1985-08-26
DE2824535A1 (de) 1978-12-14
AT364084B (de) 1981-09-25
SG65383G (en) 1985-03-29

Similar Documents

Publication Publication Date Title
HU180042B (en) Process for producing 2,2-dimethyl-pename-3-carboxylic acid-1,1-dioxide derivatives
US4234579A (en) Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
KR840000797B1 (ko) 6β-하이드록시알킬페니실란산 유도체의 제조방법
US4276285A (en) Combinations of penicillanic acid 1,1-dioxide with 7-(D-2-[4-ethylpiperazin-2,3-dione-1-carboxamido]-2-[4-hydroxyphenyl]acetamido)-3-([1-methyl-5-tetrazolyl]thiomethyl)-3-desacetoxymethylcephalosporanic acid
US4256733A (en) Acetoxymethyl penam compounds as β-lactamase inhibitors
US4420426A (en) 6-Alpha-halopenicillanic acid 1,1-dioxides
EP0008917B1 (fr) 1,1-Dioxydes de l'acide penam-3-carboxylique, procédé pour leur préparation et compositions pharmaceutiques
EP0074783B1 (fr) 1,1-Dioxydes d'acide 2-béta-substitué 2-alpha-méthyl-(5R)-pénam-3-alpha carboxylique, inhibiteurs de béta-lactamase et les intermédiaires
US4260598A (en) Method for increasing antibacterial effectiveness of a β-lactam antibiotic
EP0181702B1 (fr) Dérivés du 1,1-dioxyde d'acide pénicillanique substitués en 6
KR850001339B1 (ko) 페니실란산 1,1-디옥사이드 및 그의 에스테르의 제조방법
US4452796A (en) 6-Aminoalkylpenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
EP0287734A1 (fr) Dérivés de péname à groupe 2-méthyle substitué
EP0083977A1 (fr) Sulfone de l'acide 6-alpha-hydroxyméthylpénicillanique, en tant qu'inhibiteur de bêta-lactamase
US4762920A (en) 6,6-Dihalopenicillanic acid 1,1-dioxides
US4714761A (en) 6,6-dihalopenicillanic acid 1,1-dioxides and process
EP0002927B1 (fr) Dérivés de l'acide pénicillanique, procédés pour leur préparation et les compositions pharmaceutiques les contenant
JPS6145993B2 (fr)
US4613462A (en) 6-substituted penicillanic acid 1,1-dioxide compounds
KR820000740B1 (ko) 페니실란산 1, 1-디옥사이드의 제조방법
KR810002025B1 (ko) 페니실란산 1, 1-디옥사이드의 제조방법
CA1119164A (fr) DIOXYDES D'ACIDE 1,1-PENICILLANIQUE SERVANT D'INHIBITEURS A LA .beta.-LACTAMASE
NZ199608A (en) Administering penicillanic acid 1,1-dioxides with beta-lactam antibiotics
NZ199601A (en) Coadministration of a cephalosporin derivative and a penicillin
JPH0534336B2 (fr)

Legal Events

Date Code Title Description
HU90 Patent valid on 900628